The more the merrier? Evidence and efficacy of immune checkpoint- and tyrosine kinase inhibitor combinations in advanced solid cancers
Article in Cancer Treatment Reviews (March 2024)
The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.
Mi-2β promotes immune evasion in melanoma by activating EZH2 methylation
Article in Nature Communications (March 2024)
Systematic review and network meta-analysis of drug combinations suggested by machine learning on genes and proteins, with the aim of improving the effectiveness of Ipilimumab in treating Melanoma
Preprint in medRxiv (May 2023)